Clinical Trial Update: Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of topical ophthalmic steroids in a modified conjunctival allergen challenge model for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Snippet

Sponsor: ORA, Inc. | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2018-11-15